Enandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Usage

1. Confirm the batch number on the Enandrol carton matches the ampoule label and verify the expiry date before handling any ampoule.
2. Inspect the sealed ampoule visually for particulate matter, discolouration, or glass integrity defects — GMP-released product should present as a clear, colourless to pale-yellow solution.
3. Snap the ampoule neck cleanly using the coloured break-ring indicator; if no ring is present, use a sterile gauze wrap to protect fingers during opening.
4. Draw the full 1 ml into a sterile syringe using an 18–21 gauge drawing needle, then swap to an appropriate injection needle (23–25 gauge, 1–1.5 inch) for intramuscular administration.
5. Inject into a large muscle group (gluteus medius, vastus lateralis) using aseptic technique; aspirate briefly, then deliver the solution slowly over 10–15 seconds to minimise site discomfort.
6. Dispose of the used ampoule and needle in an approved sharps container immediately; do not recap needles; record the batch number and injection date in a personal log to support any adverse-event follow-up.

Warnings

Frequently asked questions

Who manufactures Balkan Pharmaceuticals Enandrol and where is it produced?

Enandrol is manufactured by Balkan Pharmaceuticals, a licensed pharmaceutical company based in Chișinău, Moldova. The facility holds a manufacturing authorisation from the Moldovan National Agency of Medicines and operates under EU-aligned GMP conditions, covering qualified-person batch release, environmental monitoring, and documented process validation across its sterile liquid manufacturing lines.

What does GMP certification actually mean for a Testosterone Enanthate product like Enandrol?

GMP (Good Manufacturing Practice) certification means the production environment, equipment, personnel training, raw-material sourcing, and finished-product testing all meet formally audited standards. For Enandrol specifically, this translates to HPLC-verified potency at label claim (250 mg/ml), LAL endotoxin testing on each batch, parametric sterility assurance, and a batch record that allows full traceability from API sourcing to final release.

How does Balkan Pharmaceuticals perform batch testing on Enandrol ampoules?

Batch testing occurs at two stages: incoming API inspection using IR spectroscopy confirms raw-material identity, while finished-ampoule release testing uses HPLC-UV for content uniformity and the LAL assay for bacterial endotoxin quantification. Both tests must meet pre-established acceptance criteria before a batch receives qualified-person sign-off. Batch numbers printed on every 10-ampoule carton link each unit to its retained quality documentation.

Why are single-dose 1 ml ampoules used for Enandrol instead of multi-dose vials?

Single-dose 1 ml ampoules eliminate the repeated-puncture contamination risk inherent in multi-dose vials. Each ampoule is sealed by glass fusion, leaving no rubber stopper for coring or microbial ingress. Because the entire 1 ml volume is consumed in one injection at 250 mg/ml, there is no residual solution to degrade or become contaminated between uses, making ampoule presentation the stricter sterility standard of the two formats.

Is 250 mg/ml the right concentration for a beginner's Testosterone Enanthate cycle?

At 250 mg/ml, Enandrol is well-suited to entry-level protocols because one 1 ml ampoule delivers exactly 250 mg — a dose that falls within the commonly cited starter range of 300–500 mg per week when two ampoules are used across the week. Lower concentration per millilitre also means injection volume stays manageable, reducing site discomfort compared to 300–500 mg/ml concentrations sometimes offered in underground formats. (2) angle_used

Manufacturer

Balkan Pharmaceuticals packages Enandrol exclusively in single-dose 1 ml glass ampoules rather than multi-dose vials — a deliberate format choice that eliminates repeated-puncture contamination vectors and aligns with the company's GMP sterility commitments. Each 10-ampoule box is cartonned with a printed batch number and expiry lot code, enabling pharmacovigilance traceability from the Chișinău production site to the end user. The ampoule seal is created by glass fusion during the filling-and-closing process, a closure method validated as part of the company's container-closure integrity programme under its manufacturing authorisation. This packaging approach distinguishes Enandrol from vial-format competitors where stopper coring and septum degradation over multiple draws represent an inherent quality variable.